Microfluidic Immunoassay Market Growth: Cardiology Applications and Multiplexed Detection at the Forefront | Meticulous Blog
In 2023, the global microfluidic immunoassay market was valued at $0.92 billion, and it is expected to reach $1.59 billion by 2031. Beginning from an estimated $0.98 billion in 2024, the market is projected to grow at a CAGR of 7.3% over the forecast period of 2024 to 2031. The rise in chronic and infectious diseases is driving the demand for real-time, portable diagnostic tools that offer enhanced accuracy and sensitivity. Microfluidic immunoassay technology addresses these needs by integrating microfluidics with immunoassays, providing significant advantages over traditional laboratory-based methods. This technology miniaturizes complex laboratory processes onto a chip, reducing the need for bulky equipment, complex sample preparation, and specialized personnel. The portability and efficiency of microfluidic immunoassays make them ideal for point-of-care testing and use in low-resource environments. Download Sample Report Here @ https://www.meticulousresearch.com/downlo...